[1] Kmeid E, Nacouzi M, Hallit S, et al.Prevalence of temporomandibular joint disorder in the Lebanese population, and its association with depression, anxiety, and stress[J]. Head Face Med, 2020, 16(1): 19-30. [2] Valesan LF, Da-Cas CD, Réus JC, et al.Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis[J]. Clin Oral Investig, 2021, 25(2): 441-453 [3] Sotelo EDP, Vendruscolo CP, Fülber J, et al.Effects of joint lavage with dimethylsulfoxide on LPS-induced synovitis in horses-clinical and laboratorial aspects[J]. Vet Sci, 2020, 7(2): 57-68. [4] Sahoo RK, Galluccio F, Chang KV, et.al. Indications and future perspectives of a minimally invasive ultrasound-guided double-needle joint lavage[J]. J Med Ultrasound, 2021, 29(4): 291-293. [5] Alajbeg I, Živkovic K, Gikic M.The role of stabilization splint in the treatment of temporomandibular disorders[J]. Acta Med Croatica, 2015, 69(1): 33-43. [6] Bitiniene D, Zamaliauskiene R, Kubilius R, et al.Quality of life in patients with temporomandibular disorders. A systematic review[J]. Stomatologija, 2018, 20(1): 3-9. [7] Racich MJ.Occlusion, temporomandibular disorders, and orofacial pain: an evidence-based overview and update with recommendations[J]. J Prosthet Dent, 2018, 120(5): 678-685. [8] 张邀光, 房维. 颞下颌关节紊乱病诊断标准的研究进展[J]. 口腔医学研究, 2021, 37(12): 1069-1072. Zhang YG, Fang W.Progress of diagnostic criteria for temporomandibular disorders[J]. Journal of Oral Science Research, 2021, 37(12): 1069-1072. [9] 林雪峰, 陈伟生. RDC/TMD在中国颞下颌关节紊乱病患者分类中的临床应用[C]. 第九次全国颞下颌关节病学及学研讨会论文集, 2012: 54-55. Lin XF, Chen WS.Clinical application of RDC/TMD in the classification of temporomandibular joint disorders in China[J]. Proceedings of the 9th National Symposium on Temporomandibular Joint Epidemiology and Pathology, 2012: 54-55. [10] Ungor C, Atasoy KT, Taskesen F, et al.Long-term outcome of arthrocentesis plus hyaluronic acid injection in patients with Wilkes stage II and III temporomandibular joint internal derangement[J]. J Craniofac Surg, 2015, 26(7): 2104-2108. [11] Lee K, Chon S.Assessments of muscle thickness and tonicity of the masseter and sternocleidomastoid muscles and maximum mouth opening in patients with temporomandibular disorder[J]. Healthcare (Basel), 2021, 9(12): 1640-1651. [12] Alonso-Royo R, Sánchez-Torrelo CM, Ibáñez-Vera AJ, et al.Validity and reliability of the helkimo clinical dysfunction index for the diagnosis of temporomandibular disorders[J]. Diagnostics (Basel), 2021,11(3): 472-482. [13] Manfredini D, Rancitelli D, Ferronato G, et al.Arthrocentesis with or without additional drugs in temporomandibular joint inflammatory-degenerative disease: comparison of six treatment protocols[J]. J Oral Rehabil, 2012, 39(4): 245-251. [14] Liu F, Steinkeler A.Epidemiology, diagnosis, and treatment of temporomandibular disorders[J]. Dent Clin North Am, 2013, 57(3): 465-479. [15] Dimitroulis G.Management of temporomandibular joint disorders: a surgeon's perspective[J]. Aust Dent J, 2018, 63(Suppl 1): S79-S90. [16] 王宸, 杨璞, 张东芳, 等. 膝关节镜术中不同生理盐水继续灌洗量对早期膝关节疼痛和肿胀程度的影响[J]. 中国修复重建外科杂志, 2021, 35(2): 178-182. Wang C, Yang P, Zhang DF, et al.The effect of different continuous saline irrigation volume under arthroscopy on early postoperative pain and swelling of the knee[J]. Chinese Journal of Reparative and Reconstructive Surgery, 2021, 35(2): 178-182. [17] Gudova R, Voog-Oras Ü, Ivask O.Arthrocentesis techniques used in the treatment of temporomandibular disorders: literature review[J]. Stomatologija, 2021, 23(4): 95-100. [18] Bergstrand S, Ingstad HK, Møystad A, et al.Long-term effectiveness of arthrocentesis with and without hyaluronic acid injection for treatment of temporomandibular joint osteoarthritis[J]. J Oral Sci, 2019, 61(1): 82-88. [19] Al-Moraissi EA, Farea R, Qasem KA, et al.Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials[J]. Int J Oral Maxillofac Surg, 2020, 49(8): 1042-1056. [20] Saha FJ, Pulla A, Ostermann T, et al.Effects of occlusal splint therapy in patients with migraine or tension-type headache and comorbid temporomandibular disorder: a randomized controlled trial[J]. Medicine (Baltimore), 2019, 98(33): e16805. [21] van Grootel RJ, Buchner R, Wismeijer D, et al. Towards an optimal therapy strategy for myogenous TMD, physiotherapy compared with occlusal splint therapy in an RCT with therapy-and-patient-specific treatment durations[J]. BMC Musculoskelet Disord, 2017, 18(1): 76-93. [22] Ibi M.Inflammation and temporomandibular joint derangement[J]. Biol Pharm Bull, 2019, 42(4): 538-542. [23] Wang Y, Bao M, Hou C, et al.The Role of TNF-α in the pathogenesis of temporomandibular disorders[J]. Biol Pharm Bull, 2021, 44(12): 1801-1809. [24] Fonseca MT, Moretti EH, Marques LMM, et al. A leukotriene-dependent spleen-liver axis drives TNF production in systemic inflammation[J]. Sci Signal, 2021,14(679): eabb0969. [25] Nascimento GC, De Paula BB, Gerlach RF, et al.Temporomandibular inflammation regulates the matrix metalloproteinases MMP-2 and MMP-9 in limbic structures[J]. J Cell Physiol, 2021, 236(9): 6571-6580. [26] Ulmner M, Sugars R, Naimi-Akbar A, et al.Cytokines in temporomandibular joint synovial fluid and tissue in relation to inflammation[J]. J Oral Rehabil, 2022, 49(6): 599-607. |